NAT screening of blood and plasma donations: evolution of technology and regulatory policy*
Version of Record online: 16 SEP 2002
Volume 42, Issue 9, pages 1230–1237, September 2002
How to Cite
Tabor, E. and Epstein, J. S. (2002), NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion, 42: 1230–1237. doi: 10.1046/j.1537-2995.2002.00183.x
BLA = Biologics License Application; IND(s) = investigational new drug application(s).
Presented in part at the annual meeting of the Society for Japanese Blood Programme, September 26, 2001. Portions were published in the proceedings of that meeting in Blood Programme (Ketsueki Jigyou) 2002;24:550-4, the journal of the Society for Japanese Blood Programme.
- Issue online: 16 SEP 2002
- Version of Record online: 16 SEP 2002
- Received for publication February 22, 2002; revision received April 29, 2002, and accepted May 8, 2002.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.